Search results
Can Chemo Benefit Older Patients With Pancreatic Cancer?
Medscape· 9 hours agoBetter tools are needed to identify vulnerable older patients with metastatic pancreatic cancer who...
UK Markey Cancer Center is expanding a key program, but losing its architect
Lexington Herald-Leader McClatchy via AOL· 7 days agoUniversity of Kentucky’s precision medicine tailors treatment to individual patients by taking into...
CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab,...
Benzinga· 6 days agoSugemalimab is expected to become the first anti-PD-L1 monoclonal antibody (mAb) in the world approved in Europe for both first-line squamous and non-squamous NSCLC, regardless of PD-L1...
The MUHC Foundation’s Le Bal Rouge Gala Raises a record-breaking $2,050,000 million for Cancer...
Digital Journal· 3 days agoThe MUHC Foundation backs the most innovative cancer researchers in the province. This year’s Le Bal Rouge gala supported the Cancer Research Program of ...
Once-Popular Seasonings People Stopped Using
Mashed via Yahoo News· 1 day agoThey are also known to lower cholesterol, they may have cancer-fighting properties, and they can help kill off harmful bacteria in the body. Because of...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 3 days agoCARsgen Presents Updated Results on Satri-cel in Nature Medicine and at 2024 ASCO PR Newswire SHANGHAI, June 4, 2024 SHANGHAI, June 4, 2024 /PRNewswire/ -- CARsgen Therapeutics ...
In Treating IBD, Consider Diet and Dentistry
Medscape· 2 days agoDr David Johnson highlights five compelling studies from this year's Digestive Disease Week exploring the role of oral health, diet, and intestinal...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 3 days agoRNAi Therapeutics and Technology Market Worth USD 5.36 Billion by 2031 at 16.6% CAGR- Exclusive Report by InsightAce Analytic Pvt. Ltd. PR Newswire JERSEY CITY, N.J., June 4, 2024 JERSEY CITY, N.J., June 4, 2024 /PRNewswire/ -- InsightAce Analytic
Moderna & Merck Announce 3-Year Data For mRNA-4157 (V940) in Combination With KEYTRUDA(R)...
Digital Journal· 4 days agoAt a median planned follow-up of the Phase 2b study at 34.9 months, mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 49% and the risk of distant metastasis ...
After nearly a half century, a 'mom and pop' medical practice takes a bow
The Day, New London, Conn. via Yahoo News· 6 days agoJun. 1—NORWICH — For 48 years, they did it their way. Dr. Jan Akus and his wife, Sandra, his office manager, both 75, marked the end of their medical careers Friday, the last day of business ...